Regional brain cytochrome oxidase activity in β-amyloid precursor protein transgenic mice with the swedish mutation

[1]  M. Staufenbiel,et al.  Spatial learning, exploration, anxiety, and motor coordination in female APP23 transgenic mice with the Swedish mutation , 2002, Brain Research.

[2]  M. Staufenbiel,et al.  Amyloid-Associated Neuron Loss and Gliogenesis in the Neocortex of Amyloid Precursor Protein Transgenic Mice , 2002, The Journal of Neuroscience.

[3]  J. Land,et al.  β‐Amyloid inhibits integrated mitochondrial respiration 
and key enzyme activities , 2001, Journal of neurochemistry.

[4]  F. Gonzalez-Lima,et al.  Reduced corpus callosum, fornix and hippocampus in PDAPP transgenic mouse model of Alzheimer's disease , 2001, Neuroreport.

[5]  George Paxinos,et al.  The Mouse Brain in Stereotaxic Coordinates , 2001 .

[6]  P. Ince,et al.  Mitochondrial enzyme-deficient hippocampal neurons and choroidal cells in AD , 2001, Neurology.

[7]  A. Convit,et al.  Hippocampal formation glucose metabolism and volume losses in MCI and AD , 2001, Neurobiology of Aging.

[8]  F Gonzalez-Lima,et al.  Energy Hypometabolism in Posterior Cingulate Cortex of Alzheimer's Patients: Superficial Laminar Cytochrome Oxidase Associated with Disease Duration , 2001, The Journal of Neuroscience.

[9]  M. Staufenbiel,et al.  Spontaneous Hemorrhagic Stroke in a Mouse Model of Cerebral Amyloid Angiopathy , 2001, The Journal of Neuroscience.

[10]  J. Parks,et al.  Neurotoxic Aβ peptides increase oxidative stress in vivo through NMDA‐receptor and nitric‐oxide‐synthase mechanisms, and inhibit complex IV activity and induce a mitochondrial permeability transition in vitro , 2001, Journal of neurochemistry.

[11]  G. V. Van Hoesen,et al.  Selective pathological changes of the periaqueductal gray matter in Alzheimer's disease , 2000, Annals of neurology.

[12]  G. Alexander,et al.  The neurometabolic landscape of cognitive decline: in vivo studies with positron emission tomography in Alzheimer's disease. , 2000, International journal of psychophysiology : official journal of the International Organization of Psychophysiology.

[13]  F. Leuven,et al.  Single and multiple transgenic mice as models for Alzheimer’s disease , 2000, Progress in Neurobiology.

[14]  Frederik Barkhof,et al.  Unbiased whole-brain analysis of gray matter loss in Alzheimer's disease , 2000, Neuroscience Letters.

[15]  H. Möller,et al.  A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients , 2000, Neurobiology of Aging.

[16]  A. Nunomura,et al.  Mitochondrial abnormalities in Alzheimer disease , 2000, Neurobiology of Aging.

[17]  Keith A. Johnson,et al.  Perfusion abnormalities in prodromal AD , 2000, Neurobiology of Aging.

[18]  C. Czech,et al.  Presenilins and Alzheimer’s disease: biological functions and pathogenic mechanisms , 2000, Progress in Neurobiology.

[19]  T. Town,et al.  Soluble β-amyloid peptides mediate vasoactivity via activation of a pro-inflammatory pathway , 2000, Neurobiology of Aging.

[20]  J. C. Torre,et al.  Critically attained threshold of cerebral hypoperfusion: the CATCH hypothesis of Alzheimer’s pathogenesis , 2000, Neurobiology of Aging.

[21]  P. Adlard,et al.  The cause of neuronal degeneration in Alzheimer's disease , 2000, Progress in Neurobiology.

[22]  Chantal Mathis,et al.  Early regional cerebral glucose hypometabolism in transgenic mice overexpressing the V717F β-amyloid precursor protein , 1999, Neuroscience Letters.

[23]  P. Lantos,et al.  β‐Amyloid deposition and neurofibrillary tangle formation in the olfactory bulb in ageing and Alzheimer’s disease , 1999 .

[24]  S. Rapoport,et al.  Functional Brain Imaging in the Resting State and during Activation in Alzheimer's Disease: Implications for Disease Mechanisms Involving Oxidative Phosphorylation , 1999, Annals of the New York Academy of Sciences.

[25]  M. Frotscher,et al.  Cerebral Amyloid Induces Aberrant Axonal Sprouting and Ectopic Terminal Formation in Amyloid Precursor Protein Transgenic Mice , 1999, The Journal of Neuroscience.

[26]  M. Wong-Riley,et al.  Expression and regulation of NMDA receptor subunit R1 and neuronal nitric oxide synthase in cortical neuronal cultures: Correlation with cytochrome oxidase , 1999, Journal of neurocytology.

[27]  D. Selkoe,et al.  Translating cell biology into therapeutic advances in Alzheimer's disease , 1999, Nature.

[28]  Chris I. De Zeeuw,et al.  GATA-3 Is Involved in the Development of Serotonergic Neurons in the Caudal Raphe Nuclei , 1999, The Journal of Neuroscience.

[29]  B. Sommer,et al.  Association of microglia with amyloid plaques in brains of APP23 transgenic mice. , 1999, The American journal of pathology.

[30]  D. Dickson.  Microglia in Alzheimer's disease and transgenic models. How close the fit? , 1999, The American journal of pathology.

[31]  Jae-Young Koh,et al.  Histochemically Reactive Zinc in Plaques of the Swedish Mutant β-Amyloid Precursor Protein Transgenic Mice , 1999, The Journal of Neuroscience.

[32]  Sarah Tomlin,et al.  Microtechnology: Laying it on thick , 1999, Nature.

[33]  M. Esiri,et al.  Mitochondrial enzyme expression in the hippocampus in relation to Alzheimer-type pathology , 1999, Acta Neuropathologica.

[34]  Veerle Baekelandt,et al.  Early Phenotypic Changes in Transgenic Mice That Overexpress Different Mutants of Amyloid Precursor Protein in Brain* , 1999, The Journal of Biological Chemistry.

[35]  S. Kish,et al.  Decreased Brain Protein Levels of Cytochrome Oxidase Subunits in Alzheimer's Disease and in Hereditary Spinocerebella Ataxia Disorders , 1999, Journal of neurochemistry.

[36]  D. Borchelt,et al.  SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein , 1999, Nature Neuroscience.

[37]  D. Cassarino,et al.  An evaluation of the role of mitochondria in neurodegenerative diseases: mitochondrial mutations and oxidative pathology, protective nuclear responses, and cell death in neurodegeneration , 1999, Brain Research Reviews.

[38]  T. Rosahl,et al.  Transgenic animals relevant to Alzheimer’s disease , 1999, Neuropharmacology.

[39]  B. Sommer,et al.  Neuron loss in APP transgenic mice , 1998, Nature.

[40]  C. Jack,et al.  Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease , 1998, Neurology.

[41]  D. Sirinathsinghji.  Transgenic mouse models of Alzheimer's disease. , 1998, Biochemical Society transactions.

[42]  R. Lalonde,et al.  Regional brain variations of cytochrome oxidase activity and motor coordination in Lurcher mutant mice , 1998, Experimental Brain Research.

[43]  G. Alexander,et al.  Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease , 1998, Neurology.

[44]  M. Tabaton,et al.  Amyloid‐β Deposition in Alzheimer Transgenic Mice Is Associated with Oxidative Stress , 1998, Journal of neurochemistry.

[45]  B. Sommer,et al.  Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[46]  R. Davis,et al.  Cybrids in Alzheimer's disease: A cellular model of the disease? , 1997, Neurology.

[47]  Rudolph E Tanzi,et al.  Presenilins and Alzheimer's disease , 1997, Current Opinion in Neurobiology.

[48]  B. Hyman,et al.  APPSW Transgenic Mice Develop Age‐related Aβ Deposits and Neuropil Abnormalities, but no Neuronal Loss in CA1 , 1997, Journal of neuropathology and experimental neurology.

[49]  S. Younkin,et al.  Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice , 1996, Science.

[50]  D. Borchelt,et al.  Inherited Neurodegenerative Diseases and Transgenic Models , 1996, Brain pathology.

[51]  L. Mucke,et al.  Comparison of Neurodegenerative Pathology in Transgenic Mice Overexpressing V717F β-Amyloid Precursor Protein and Alzheimer’s Disease , 1996, The Journal of Neuroscience.

[52]  D. Premkumar,et al.  Molecular aspects of inflammatory and immune responses in Alzheimer's disease , 1996, Neurobiology of Aging.

[53]  D. Borchelt,et al.  Age-related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins , 1995, Neuron.

[54]  P. Chagnon,et al.  Distribution of brain cytochrome oxidase activity in various neurodegenerative diseases. , 1995, Neuroreport.

[55]  J. Parks,et al.  Cytochrome C Oxidase in Alzheimer's Disease Brain , 1995, Neurology.

[56]  L. Mucke,et al.  Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein , 1995, Nature.

[57]  Dirk Jones,et al.  Quantitative mapping of cytovhrome oxidase activity in the central auditory system of the gerbil: a study with calibrated activity standards and metal-intensified histochemistry , 1994, Brain Research.

[58]  T. Iwatsubo,et al.  Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ42(43) , 1994, Neuron.

[59]  H. Reichmann,et al.  Electron transport chain defects in Alzheimer's disease. , 1994, Neurology.

[60]  H. T. ter Laak,et al.  The Olfactory Bulb in Alzheimer Disease: A Morphologic Study of Neuron Loss, Tangles, and Senile Plaques in Relation to Olfaction , 1994, Alzheimer disease and associated disorders.

[61]  P. Greengard,et al.  Altered processing of Alzheimer amyloid precursor protein in response to neuronal degeneration. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[62]  M. Wong-Riley,et al.  Mitochondrial and nuclear gene expression for cytochrome oxidase subunits are disproportionately regulated by functional activity in neurons , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[63]  J. Nobrega,et al.  Brain Cytochrome Oxidase in Alzheimer's Disease , 1992, Journal of neurochemistry.

[64]  G Blomqvist,et al.  Brain metabolism in Alzheimer's dementia: studies of 11C-deoxyglucose accumulation, CSF monoamine metabolites and neuropsychological test performance in patients and healthy subjects. , 1991, Journal of neurology, neurosurgery, and psychiatry.

[65]  C. Filley,et al.  Cytochrome oxidase deficiency in Alzheimer's disease , 1990, Neurology.

[66]  M. Wong-Riley.  Cytochrome oxidase: an endogenous metabolic marker for neuronal activity , 1989, Trends in Neurosciences.

[67]  R. Terry,et al.  Senile dementia of the Alzheimer type , 1983, Annals of neurology.

[68]  Michael W. Miller,et al.  Cortical connections between rat cingulate cortex and visual, motor, and postsubicular cortices , 1983, The Journal of comparative neurology.

[69]  M. Wong-Riley.  Changes in the visual system of monocularly sutured or enucleated cats demonstrable with cytochrome oxidase histochemistry , 1979, Brain Research.

[70]  O. Lindvall,et al.  Subcortical projections to the prefrontal cortex in the rat as revealed by the horseradish peroxidase technique , 1978, Neuroscience.

[71]  H. Hess,et al.  Ultramicrospectrophotometric determination of cytochrome oxidase for quantitative histochemistry. , 1953, The Journal of biological chemistry.

[72]  H. Braak,et al.  The autonomic higher order processing nuclei of the lower brain stem are among the early targets of the Alzheimer's disease-related cytoskeletal pathology , 2001, Acta Neuropathologica.

[73]  M. Beal,et al.  Mitochondria and free radicals in neurodegenerative diseases , 1997 .

[74]  G. Paxinos.  The Rat nervous system , 1985 .